Covered recipient · General Payments record
SAMANTHA A ESPOSITO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$2,399.30
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,248.83 | 54 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $298.43 | 10 |
| ABBVIE INC. | $276.87 | 10 |
| Astellas Pharma US Inc | $170.94 | 11 |
| PFIZER INC. | $119.82 | 5 |
| Novo Nordisk AS | $114.10 | 6 |
| Lilly USA, LLC | $97.97 | 5 |
| Abbott Laboratories | $84.96 | 4 |
| Sage Therapeutics, Inc. | $36.03 | 1 |
| Valneva USA, Inc. | $29.45 | 1 |
| Daiichi Sankyo Inc. | $20.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.26 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125131322 | CMS |
| Abbott Laboratories | $22.60 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125131324 | CMS |
| Abbott Laboratories | $18.63 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125131326 | CMS |
| Abbott Laboratories | $22.47 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125131328 | CMS |
| ABBVIE INC. | $33.87 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103699658 | CMS |
| ABBVIE INC. | $31.38 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103699660 | CMS |
| ABBVIE INC. | $30.57 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103699662 | CMS |
| ABBVIE INC. | $11.92 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103699664 | CMS |
| ABBVIE INC. | $33.82 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103699666 | CMS |
| ABBVIE INC. | $30.20 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103699668 | CMS |
| ABBVIE INC. | $32.51 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103699670 | CMS |
| ABBVIE INC. | $7.23 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103699672 | CMS |
| ABBVIE INC. | $34.49 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103699674 | CMS |
| ABBVIE INC. | $30.88 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103699676 | CMS |
| Astellas Pharma US Inc | $16.33 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139474228 | CMS |
| Astellas Pharma US Inc | $2.74 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139482116 | CMS |
| Astellas Pharma US Inc | $17.88 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139495174 | CMS |
| Astellas Pharma US Inc | $16.52 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139499670 | CMS |
| Astellas Pharma US Inc | $12.13 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139501984 | CMS |
| Astellas Pharma US Inc | $19.77 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139509971 | CMS |
| Astellas Pharma US Inc | $16.63 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139520309 | CMS |
| Astellas Pharma US Inc | $19.47 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139535938 | CMS |
| Astellas Pharma US Inc | $10.61 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139539316 | CMS |
| Astellas Pharma US Inc | $20.83 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139548703 | CMS |
| Astellas Pharma US Inc | $18.03 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139557249 | CMS |
| Daiichi Sankyo Inc. | $20.26 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089419792 | CMS |
| Dexcom, Inc. | $15.43 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384636 | CMS |
| Dexcom, Inc. | $73.85 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384634 | CMS |
| Dexcom, Inc. | $15.74 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384638 | CMS |
| Dexcom, Inc. | $0.96 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384640 | CMS |
| Dexcom, Inc. | $1.88 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384642 | CMS |
| Dexcom, Inc. | $17.29 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384644 | CMS |
| Dexcom, Inc. | $126.58 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384646 | CMS |
| Dexcom, Inc. | $1.99 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384648 | CMS |
| Dexcom, Inc. | $15.48 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384650 | CMS |
| Dexcom, Inc. | $29.23 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384652 | CMS |
| Lilly USA, LLC | $19.75 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135940860 | CMS |
| Lilly USA, LLC | $22.84 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135902398 | CMS |
| Lilly USA, LLC | $17.50 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135927000 | CMS |
| Lilly USA, LLC | $19.12 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135957471 | CMS |
| Lilly USA, LLC | $18.76 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135957473 | CMS |
| Novo Nordisk Inc | $19.85 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100279818 | CMS |
| Novo Nordisk Inc | $23.39 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100373677 | CMS |
| Novo Nordisk Inc | $17.24 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100428821 | CMS |
| Novo Nordisk Inc | $17.33 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100314397 | CMS |
| Novo Nordisk Inc | $20.17 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100329954 | CMS |
| Novo Nordisk Inc | $16.12 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100474314 | CMS |
| PFIZER INC. | $25.83 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131534265 | CMS |
| PFIZER INC. | $28.01 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131692594 | CMS |
| PFIZER INC. | $23.78 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131708810 | CMS |
| PFIZER INC. | $24.95 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131944966 | CMS |
| PFIZER INC. | $17.25 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132081596 | CMS |
| Sage Therapeutics, Inc. | $36.03 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120392161 | CMS |
| Valneva Usa, Inc. | $29.45 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121128272 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.